Association of Traditional Chinese Medicine Body Constitution and Moderate-to-severe Cancer-related Fatigue in Cancer Patients
Overview
Affiliations
Background And Purpose: Fatigue is one of the most prevalent adverse events reported by cancer patients. The aim of this study was to investigate the association between traditional Chinese medicine body constitution (TCMBC) and moderate-to-severe cancer-related fatigue in cancer patients.
Materials And Methods: A cross-sectional study was conducted on cancer patients recruited from a regional hospital in southern Taiwan. The association between TCMBC, measured using the Constitution in Chinese Medicine Questionnaire (CCMQ) and moderate-to-severe cancer-related fatigue (based on the Taiwanese version of the Brief Fatigue Inventory score ≥ 4) was evaluated using multiple logistic regression analysis.
Results: Of the 170 participants, 37 (21.8%) had moderate-to-severe fatigue. Yang-deficiency (adjusted odds ratio [aOR] = 3.55, 95% confidence interval [CI] = 1.50-8.40) and Qi-deficiency (aOR = 2.84, 95% CI = 1.18-6.82) TCMBC were significantly associated with moderate-to-severe cancer-related fatigue.
Conclusion: TCMBC could be used as a clinical tool to identify cancer patients prone to experience moderate-to-severe cancer-related fatigue, and to provide Chinese medicine practitioners a basis for selecting an appropriate treatment approach based on TCMBC.
Chan A, Chan D, Ng D, Zheng H, Tan Q, Tan C Integr Cancer Ther. 2025; 24():15347354251314514.
PMID: 39840742 PMC: 11755541. DOI: 10.1177/15347354251314514.
Guo K, Wang Z, Su X Chin J Integr Med. 2024; .
PMID: 39331211 DOI: 10.1007/s11655-024-4115-8.
Nie X, Wang C, Zhang H, Liu Q, Hou L, Deng Y Aging Med (Milton). 2024; 7(3):334-340.
PMID: 38975312 PMC: 11222750. DOI: 10.1002/agm2.12328.
Darvishi E, Musarezaie A, Bahrami M, Karimian J Iran J Nurs Midwifery Res. 2023; 28(4):398-404.
PMID: 37694198 PMC: 10484386. DOI: 10.4103/ijnmr.ijnmr_399_22.
Governor vessel moxibustion for cancer-related fatigue in colorectal patients: a randomized trial.
Li H, Huang W, Du K, Liu W, Wu Z, Xu B Front Oncol. 2023; 13:1199200.
PMID: 37397368 PMC: 10311481. DOI: 10.3389/fonc.2023.1199200.